Russell Investments Group
AMED

Russell Investments Group’s Amedisys AMED Stock Holding History

Russell Investments Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,384
Closed -$431K – 4144
2025
Q2 		$431K Buy
4,384
+2,944
+204% +$279K ﹤0.01% 2389
2025
Q1 		$133K Buy
1,440
+481
+50% +$44.3K ﹤0.01% 2688
2024
Q4 		$87.1K Sell
959
-300
-24% -$27.6K ﹤0.01% 2710
2024
Q3 		$122K Sell
1,259
-270
-18% -$26.3K ﹤0.01% 2608
2024
Q2 		$140K Sell
1,529
-28
-2% -$2.6K ﹤0.01% 2553
2024
Q1 		$143K Sell
1,557
-18,992
-92% -$1.78M ﹤0.01% 2515
2023
Q4 		$1.95M Sell
20,549
-1,637
-7% -$153K ﹤0.01% 1623
2023
Q3 		$2.07M Sell
22,186
-237
-1% -$21.9K ﹤0.01% 1523
2023
Q2 		$2.05M Sell
22,423
-10,544
-32% -$865K ﹤0.01% 1553
2023
Q1 		$2.42M Buy
32,967
+11,393
+53% +$986K ﹤0.01% 1464
2022
Q4 		$1.8M Buy
21,574
+6,254
+41% +$564K ﹤0.01% 1658
2022
Q3 		$1.48M Sell
15,320
-27,979
-65% -$3.34M ﹤0.01% 1725
2022
Q2 		$4.55M Buy
43,299
+43,088
+20,421% +$5.5M 0.01% 1147
2022
Q1 		$36K Sell
211
-5,070
-96% -$757K ﹤0.01% 2645
2021
Q4 		$855K Sell
5,281
-3,135
-37% -$504K ﹤0.01% 2231
2021
Q3 		$1.25M Sell
8,416
-37,662
-82% -$7.83M ﹤0.01% 2084
2021
Q2 		$11.4M Sell
46,078
-11,625
-20% -$3.05M 0.02% 868
2021
Q1 		$15.1M Buy
57,703
+614
+1% +$173K 0.03% 718
2020
Q4 		$16.5M Buy
57,089
+1,183
+2% +$303K 0.03% 590
2020
Q3 		$13M Sell
55,906
-20,189
-27% -$4.59M 0.03% 642
2020
Q2 		$15M Sell
76,095
-46,740
-38% -$8.72M 0.03% 564
2020
Q1 		$22.3M Sell
122,835
-638
-0.5% -$114K 0.06% 362
2019
Q4 		$20.6M Buy
123,473
+4,089
+3% +$608K 0.04% 531
2019
Q3 		$15.5M Sell
119,384
-45,985
-28% -$5.99M 0.03% 646
2019
Q2 		$19.9M Buy
165,369
+27,954
+20% +$3.32M 0.04% 567
2019
Q1 		$16.6M Buy
137,415
+40,769
+42% +$5.12M 0.03% 648
2018
Q4 		$11.1M Buy
96,646
+33,425
+53% +$3.94M 0.02% 751
2018
Q3 		$7.74M Buy
63,221
+32,246
+104% +$3.56M 0.01% 1072
2018
Q2 		$2.66M Buy
30,975
+27,964
+929% +$2.05M 0.01% 1627
2018
Q1 		$182K Hold
3,011
– – ﹤0.01% 2673
2017
Q4 		$159K Hold
3,011
– – ﹤0.01% 2706
2017
Q3 		$169K Sell
3,011
-273,797
-99% -$14.5M ﹤0.01% 2698
2017
Q2 		$17.4M Buy
276,808
+240,513
+663% +$14M 0.03% 661
2017
Q1 		$1.85M Buy
36,295
+15,875
+78% +$757K ﹤0.01% 1792
2016
Q4 		$870K Buy
+20,420
New +$868K ﹤0.01% 2252

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Russell Investments Group's AMED Position: Q3 2025 in Review

Russell Investments Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,384 shares — an estimated $431K sold.

Russell Investments Group first reported a position in AMED in Q4 2016 and held it in 35 quarters. The position peaked at $22.3M in Q1 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Russell Investments Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Russell Investments Group sold 4,384 Amedisys shares in Q3 2025, an estimated $431K.
  • Russell Investments Group first reported a position in Amedisys in Q4 2016 and held it in 35 quarters.
  • Russell Investments Group's Amedisys position peaked at $22.3M in Q1 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.